Annual Conference 2018

142 - The Ins and Outs of Medications Affecting Bladder Function

Oct 26, 2018 1:20pm ‐ Oct 26, 2018 2:20pm


Description

Many common medications can contribute to bladder dysfunction. In this session we review several medications that may be causative agents in bladder dysfunction or be associated with drug interactions with common agents used to treat urinary disorders. Participants will leave with increased confidence in optimizing pharmacotherapy to avoid bladder-associated complications.

Continuing Education Instructions and Disclosure Information

Contact hours available until 10/28/2020.

Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online CNE evaluation. You will be able to print your CNE certificate at any time after you complete the evaluation.

Planning Committee Disclosures: Heather Schultz, MSN, RN, NP-C - AUA Leadership Position 2018 Program Planner

Speakers Conflict of Interest Disclosure: There are no disclosures to declare.

Commercial Support and Sponsorship:
No commercial support or sponsorship declared.

Accreditation Statement:

The Society of Urologic Nurses and Associates (SUNA) is accredited as a provider of continuing nursing education by the American Nurses’ Credentialing Center’s Commission on Accreditation.

The SUNA accreditation is reciprocal in the states and specialty organizations that recognize the ANCC-COA accreditation process. SUNA is also a provider approved by the California Board of Registered Nursing, Provider Number CEP 5556. Accreditation and approved provider status of CE in nursing does not imply ANCC-COA approval or endorsement of any product, advertising, or educational content. SUNA urges all participants to be aware of the CE requirements for re-licensure in the states in which they hold a license.

Learning Outcome:
After completing this continuing nursing education activity the learner will have increased competency in reviewing comprehensive medication lists and identifying & considering pharmacodynamic drug-drug and drug-disease state interactions when managing urologic therapies.

Speaker(s):

You must be logged in and own this session in order to post comments.